SiNtx Technologies Inc (SINT) Actualités

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Strategic Transaction Enhances Financial Flexibility and Supports Growth in Healthcare Innovations Salt Lake...

Form 8-K - Current report

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Salt Lake City, Utah, Feb. 19, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

Salt Lake City, Utah, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...

Form 8-K - Current report

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment

Salt Lake City, UT, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the...

Form 8-K - Current report

SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer

Seasoned Healthcare Executive to Lead Strategic Growth Initiatives Salt Lake City, UT, Nov. 19, 2024 (GLOBE...

Form 8-K - Current report

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]